Why the study?
Despite growing evidence for renal denervation in a broad patient population, questions remain regarding its suitability, practical implementation, and navigation of rapidly emerging data.
This review provides practical, evidence-based guidance for health professionals on the implementation of renal denervation for hypertension management.
Answers are grounded in this paper and cite their sources.
May guide hypertension teams considering renal denervation; leaves open need for updated randomized outcome data.
Growing evidence demonstrates the suitability of renal denervation in a broad population of patients; however, questions remain over its suitability and practical implementation. Given the rapidity of emerging data, this has been a challenging field for potential adopters to navigate. The purpose of this article is twofold: to provide navigation through emerging clinical data and evolving guidance; and to provide physicians with practical, evidence-based advice for identifying eligible patients and providing appropriate management in the pre- and postintervention settings. Although many of these recommendations are based on existing published guidance documents, we reflect equally on our own experiences of using this technology.
No takes yet. Share an insight, caveat, or question.
Schmieder et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: